Mycobacterium avium complex sputum isolates from patients with respiratory symptoms in Guinea-Bissau. 1996

T Koivula, and S Hoffner, and N Winqvist, and A Nauclér, and F Dias, and L Lacerda, and S Svenson, and R Norberg, and G Källenius
Swedish Institute for Infectious Disease Control, Karolinska Institute, Stockholm, Sweden.

In total, 814 patients with clinically suspected tuberculosis were examined at the Raoul Follerau Hospital in Bissau, Guinea-Bissau. Sputum samples were collected, and cultures were grown on Löwenstein-Jensen medium. Isolates were further characterized by standard biochemical methods and nucleic acid probes for Mycobacterium tuberculosis and Mycobacterium avium complex (MAC). Serum samples were collected and analyzed for antibodies against human immunodeficiency virus (HIV) types 1 and 2. Of 17 patients who had MAC organisms in sputum, 2 were HIV-2-positive and none was HIV-1-positive. Of the total 814 patients, 189 had culture-verified tuberculosis; 36 (19%) of them were HIV-2-positive. Thus, of 206 patients with sputum culture positive for M. tuberculosis or MAC, 17 (8%) had MAC organisms in sputum. MAC infection may be the cause of some treatment failures in areas where MAC pulmonary infection is common.

UI MeSH Term Description Entries
D008297 Male Males
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D006169 Guinea-Bissau A republic in western Africa, south of SENEGAL and west of GUINEA. Its capital is Bissau. Guinea, Portuguese,Portuguese Guinea,Guinea-Bissau, Republic of,Republic of Guinea-Bissau
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001431 Bacteriological Techniques Techniques used in studying bacteria. Bacteriologic Technic,Bacteriologic Technics,Bacteriologic Techniques,Bacteriological Technique,Technic, Bacteriological,Technics, Bacteriological,Technique, Bacteriological,Techniques, Bacteriological,Bacteriologic Technique,Bacteriological Technic,Bacteriological Technics,Technic, Bacteriologic,Technics, Bacteriologic,Technique, Bacteriologic,Techniques, Bacteriologic
D013183 Sputum Material coughed up from the lungs and expectorated via the mouth. It contains MUCUS, cellular debris, and microorganisms. It may also contain blood or pus. Sputum, Induced,Induced Sputum,Induced Sputums,Sputums,Sputums, Induced

Related Publications

T Koivula, and S Hoffner, and N Winqvist, and A Nauclér, and F Dias, and L Lacerda, and S Svenson, and R Norberg, and G Källenius
November 2004, Microbes and infection,
T Koivula, and S Hoffner, and N Winqvist, and A Nauclér, and F Dias, and L Lacerda, and S Svenson, and R Norberg, and G Källenius
August 1993, Journal of clinical microbiology,
T Koivula, and S Hoffner, and N Winqvist, and A Nauclér, and F Dias, and L Lacerda, and S Svenson, and R Norberg, and G Källenius
April 1998, Journal of medical microbiology,
T Koivula, and S Hoffner, and N Winqvist, and A Nauclér, and F Dias, and L Lacerda, and S Svenson, and R Norberg, and G Källenius
May 1998, Kekkaku : [Tuberculosis],
T Koivula, and S Hoffner, and N Winqvist, and A Nauclér, and F Dias, and L Lacerda, and S Svenson, and R Norberg, and G Källenius
January 2000, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,
T Koivula, and S Hoffner, and N Winqvist, and A Nauclér, and F Dias, and L Lacerda, and S Svenson, and R Norberg, and G Källenius
November 1988, Diagnostic microbiology and infectious disease,
T Koivula, and S Hoffner, and N Winqvist, and A Nauclér, and F Dias, and L Lacerda, and S Svenson, and R Norberg, and G Källenius
December 1992, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
T Koivula, and S Hoffner, and N Winqvist, and A Nauclér, and F Dias, and L Lacerda, and S Svenson, and R Norberg, and G Källenius
August 1996, Antimicrobial agents and chemotherapy,
T Koivula, and S Hoffner, and N Winqvist, and A Nauclér, and F Dias, and L Lacerda, and S Svenson, and R Norberg, and G Källenius
April 2011, PloS one,
T Koivula, and S Hoffner, and N Winqvist, and A Nauclér, and F Dias, and L Lacerda, and S Svenson, and R Norberg, and G Källenius
January 2004, The Journal of infectious diseases,
Copied contents to your clipboard!